Literature DB >> 35348593

Dietary Patterns and Gut Microbiota: The Crucial Actors in Inflammatory Bowel Disease.

Pandi He1,2, Leilei Yu1,2, Fengwei Tian1,2, Hao Zhang1,2,3,4, Wei Chen1,2,3, Qixiao Zhai1,2.   

Abstract

It is widely believed that diet and the gut microbiota are strongly related to the occurrence and progression of inflammatory bowel disease (IBD), but the effects of the interaction between dietary patterns and the gut microbiota on IBD have not been well elucidated. In this article, we aim to explore the complex relation between dietary patterns, gut microbiota, and IBD. We first comprehensively summarized the dietary patterns associated with IBD and found that dietary patterns can modulate the occurrence and progression of IBD through various signaling pathways, including mammalian target of rapamycin (mTOR), mitogen-activated protein kinases (MAPKs), signal transducer and activator of transcription 3 (STAT3), and NF-κB. Besides, the gut microbiota performs a vital role in the progression of IBD, which can affect the expression of IBD susceptibility genes, such as dual oxidase 2 (DUOX2) and APOA-1 , the intestinal barrier (in particular, the expression of tight junction proteins), immune function (especially the homeostasis between effector and regulatory T cells) and the physiological metabolism, in particular, SCFAs, bile acids (BAs), and tryptophan metabolism. Finally, we reviewed the current knowledge on the interaction between dietary patterns and the gut microbiota in IBD and found that dietary patterns modulate the onset and progression of IBD, which is partly attributed to the regulation of the gut microbiota (especially SCFAs-producing bacteria and Escherichia coli). Faecalibacteria as "microbiomarkers" of IBD could be used as a target for dietary interventions to alleviate IBD. A comprehensive understanding of the interplay between dietary intake, gut microbiota, and IBD will facilitate the development of personalized dietary strategies based on the regulation of the gut microbiota in IBD and expedite the era of precision nutritional interventions for IBD.
© The Author(s) 2022. Published by Oxford University Press on behalf of the American Society for Nutrition.

Entities:  

Keywords:  bile acids; dietary patterns; dysbacteriosis; gut microbiota; inflammatory bowel disease; short chain fatty acids; tryptophan

Mesh:

Substances:

Year:  2022        PMID: 35348593      PMCID: PMC9526834          DOI: 10.1093/advances/nmac029

Source DB:  PubMed          Journal:  Adv Nutr        ISSN: 2161-8313            Impact factor:   11.567


  227 in total

1.  Desulfovibrio bacterial species are increased in ulcerative colitis.

Authors:  Fiachra Rowan; Neil G Docherty; Madeline Murphy; Brendan Murphy; John Calvin Coffey; P Ronan O'Connell
Journal:  Dis Colon Rectum       Date:  2010-11       Impact factor: 4.585

Review 2.  Intestinal epithelial cells: regulators of barrier function and immune homeostasis.

Authors:  Lance W Peterson; David Artis
Journal:  Nat Rev Immunol       Date:  2014-03       Impact factor: 53.106

3.  Sodium chloride-enriched Diet Enhanced Inflammatory Cytokine Production and Exacerbated Experimental Colitis in Mice.

Authors:  Ivan Monteleone; Irene Marafini; Vincenzo Dinallo; Davide Di Fusco; Edoardo Troncone; Francesca Zorzi; Federica Laudisi; Giovanni Monteleone
Journal:  J Crohns Colitis       Date:  2016-07-29       Impact factor: 9.071

4.  Connecting dysbiosis, bile-acid dysmetabolism and gut inflammation in inflammatory bowel diseases.

Authors:  Henri Duboc; Sylvie Rajca; Dominique Rainteau; David Benarous; Marie-Anne Maubert; Elodie Quervain; Ginette Thomas; Véronique Barbu; Lydie Humbert; Guillaume Despras; Chantal Bridonneau; Fabien Dumetz; Jean-Pierre Grill; Joëlle Masliah; Laurent Beaugerie; Jacques Cosnes; Olivier Chazouillères; Raoul Poupon; Claude Wolf; Jean-Maurice Mallet; Philippe Langella; Germain Trugnan; Harry Sokol; Philippe Seksik
Journal:  Gut       Date:  2012-09-19       Impact factor: 23.059

Review 5.  Dietary intake and risk of developing inflammatory bowel disease: a systematic review of the literature.

Authors:  Jason K Hou; Bincy Abraham; Hashem El-Serag
Journal:  Am J Gastroenterol       Date:  2011-04       Impact factor: 10.864

6.  Prevalence and factors associated with gluten sensitivity in inflammatory bowel disease.

Authors:  Berkeley N Limketkai; Rachel Sepulveda; Tressia Hing; Neha D Shah; Monica Choe; David Limsui; Shamita Shah
Journal:  Scand J Gastroenterol       Date:  2017-12-07       Impact factor: 2.423

7.  Clinical and mucosal improvement with specific carbohydrate diet in pediatric Crohn disease.

Authors:  Stanley A Cohen; Benjamin D Gold; Salvatore Oliva; Jeffery Lewis; Angela Stallworth; Bailey Koch; Laura Eshee; David Mason
Journal:  J Pediatr Gastroenterol Nutr       Date:  2014-10       Impact factor: 2.839

8.  Oleuropein protects against dextran sodium sulfate-induced chronic colitis in mice.

Authors:  Elisa Giner; María-Carmen Recio; José-Luis Ríos; Rosa-María Giner
Journal:  J Nat Prod       Date:  2013-06-12       Impact factor: 4.050

9.  Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease.

Authors:  Luke Jostins; Stephan Ripke; Rinse K Weersma; Richard H Duerr; Dermot P McGovern; Ken Y Hui; James C Lee; L Philip Schumm; Yashoda Sharma; Carl A Anderson; Jonah Essers; Mitja Mitrovic; Kaida Ning; Isabelle Cleynen; Emilie Theatre; Sarah L Spain; Soumya Raychaudhuri; Philippe Goyette; Zhi Wei; Clara Abraham; Jean-Paul Achkar; Tariq Ahmad; Leila Amininejad; Ashwin N Ananthakrishnan; Vibeke Andersen; Jane M Andrews; Leonard Baidoo; Tobias Balschun; Peter A Bampton; Alain Bitton; Gabrielle Boucher; Stephan Brand; Carsten Büning; Ariella Cohain; Sven Cichon; Mauro D'Amato; Dirk De Jong; Kathy L Devaney; Marla Dubinsky; Cathryn Edwards; David Ellinghaus; Lynnette R Ferguson; Denis Franchimont; Karin Fransen; Richard Gearry; Michel Georges; Christian Gieger; Jürgen Glas; Talin Haritunians; Ailsa Hart; Chris Hawkey; Matija Hedl; Xinli Hu; Tom H Karlsen; Limas Kupcinskas; Subra Kugathasan; Anna Latiano; Debby Laukens; Ian C Lawrance; Charlie W Lees; Edouard Louis; Gillian Mahy; John Mansfield; Angharad R Morgan; Craig Mowat; William Newman; Orazio Palmieri; Cyriel Y Ponsioen; Uros Potocnik; Natalie J Prescott; Miguel Regueiro; Jerome I Rotter; Richard K Russell; Jeremy D Sanderson; Miquel Sans; Jack Satsangi; Stefan Schreiber; Lisa A Simms; Jurgita Sventoraityte; Stephan R Targan; Kent D Taylor; Mark Tremelling; Hein W Verspaget; Martine De Vos; Cisca Wijmenga; David C Wilson; Juliane Winkelmann; Ramnik J Xavier; Sebastian Zeissig; Bin Zhang; Clarence K Zhang; Hongyu Zhao; Mark S Silverberg; Vito Annese; Hakon Hakonarson; Steven R Brant; Graham Radford-Smith; Christopher G Mathew; John D Rioux; Eric E Schadt; Mark J Daly; Andre Franke; Miles Parkes; Severine Vermeire; Jeffrey C Barrett; Judy H Cho
Journal:  Nature       Date:  2012-11-01       Impact factor: 49.962

10.  Fungal microbiota dysbiosis in IBD.

Authors:  Harry Sokol; Valentin Leducq; Hugues Aschard; Hang-Phuong Pham; Sarah Jegou; Cecilia Landman; David Cohen; Giuseppina Liguori; Anne Bourrier; Isabelle Nion-Larmurier; Jacques Cosnes; Philippe Seksik; Philippe Langella; David Skurnik; Mathias L Richard; Laurent Beaugerie
Journal:  Gut       Date:  2016-02-03       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.